Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Method for improving infection efficiency of adeno-associated virus to infect cells

A technology for infecting cells and cells, which is applied in the field of biomedicine and can solve problems such as restricting the application of AAV and weak capabilities

Pending Publication Date: 2021-06-18
CHIGENOVO CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the ability of AAV to infect cell lines is very weak, especially for AAV serotypes such as AAV3, AAV4, AAV8, and AAV9. These AAVs need auxiliary infection of adenovirus to achieve effective infection, which greatly restricts the application of AAV.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving infection efficiency of adeno-associated virus to infect cells
  • Method for improving infection efficiency of adeno-associated virus to infect cells
  • Method for improving infection efficiency of adeno-associated virus to infect cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0131] CLAIMS 1. A method for increasing the infection efficiency of an adeno-associated virus (AAV)-infected cell, comprising the step of: contacting said cell to be infected with a DNA replication inhibitor.

[0132] 2. The method of embodiment 1, wherein the contacting comprises contacting in vitro.

[0133] 3. The method of any one of embodiments 1-2, wherein the contacting time is from about 0.5 to about 4 hours.

[0134] 4. The method of any one of embodiments 1-3, wherein the temperature of the contacting is from about 30°C to about 40°C.

[0135] 5. The method according to any one of embodiments 1-4, wherein said cells to be infected are contacted with a DNA replication inhibitor in a cell culture medium.

[0136] 6. The method according to embodiment 5, wherein the cell culture medium comprises DMEM medium, HAM'S F12K medium and / or FBS medium.

[0137] 7. The method according to any one of embodiments 1-6, wherein the cells comprise: HEK293 cells, 293T cells and / or ...

Embodiment 1

[0171] Example 1 Different serotypes of AAV-GFP have different infectivity and expression intensity in HEK293

[0172] HEK293 cells (ATCC, CRL-1573) were digested 24 hours in advance, and 12-well cell culture dishes (Corning, 3513) were incubated with 100 μg / ml poly-lysine (Beyond, C0313)-DPBS (Gibco, C14190500BT) solution in advance After 15 minutes, the cells were blotted dry, and the cells were counted at 1.5e5 per well. CO 2 Incubate at 37°C for 24 hours in an incubator.

[0173] After 24 hours, each well was infected with AAV2-GFP, AAV5-GFP, AAV8-GFP, AAV9-GFP and AAVDJ-GFP at MOI=3E5 respectively (wherein each AAV was purchased from Shandong Weizhen Biotechnology Co., Ltd. The described steps allow AAV to express GFP (the accession number of the GFP gene in GenBank is ID: 114976950)). Fresh DMEM-10% FBS (Gibco, 10199-141) medium was replaced every 24 hours after infection. After 2 days of infection, a fluorescent microscope (Life, AMF4305) was used to take pictures a...

Embodiment 2

[0175] Example 2 Different serotypes of AAV-GFP have different infectivity and expression intensity in CHO cells

[0176] Digest CHO-K1 cells (Wuhan Punuo, CL-0062) 24 hours in advance, and 12-well cell culture dishes (Corning, 3513) were pre-digested with 100 μg / ml poly-lysine (Gibco , C14190500BT) solution was incubated for 15min, blotted dry and plated cells, counted 1.5e5 per well. CO 2 Incubate at 37°C for 24 hours in an incubator.

[0177] After 24 hours, each well was infected with AAV2-GFP, AAV5-GFP, AAV8-GFP, AAV9-GFP, and AAVDJ-GFP at MOI=3E5, respectively. Fresh Ham's F12K (Wuhan Punuosai, PM150910)-10% FBS medium was replaced every 24 hours after infection. After 3 days of infection, photographs were taken with a fluorescent microscope, and the fluorescent expression level of GFP was detected with a microplate reader (Biotek, H1M).

[0178] The expression levels of GFP fluorescence after different serotypes of AAV-GFP infected CHO-K1 were as follows: Figure 3...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for improving infection efficiency of AAV (adeno-associated virus) to infect cells. The method comprises the following steps: making cells to-be-infected contacted with DNA replication inhibitors, wherein the DNA replication inhibitors comprise cell cycle non-specific drugs and / or CDK inhibitors. According to the method disclosed by the invention, the infection efficiency of the AAV to infect cells can be remarkably improved.

Description

technical field [0001] The present application relates to the field of biomedicine, in particular to a method for improving the infection efficiency of adeno-associated virus-infected cells. Background technique [0002] At present, adeno-associated virus (AAV) has been widely used in the field of gene therapy, which can effectively infect various organs and tissues. However, the ability of AAV to infect cell lines is very weak, especially for AAV serotypes such as AAV3, AAV4, AAV8, and AAV9. These AAVs need auxiliary infection of adenovirus to achieve effective infection, which greatly restricts the application of AAV. [0003] Therefore, there is an urgent need to improve the infection efficiency of cells infected with adeno-associated virus AAV. Contents of the invention [0004] The present application provides a method that can significantly improve the infection efficiency of cells infected with adeno-associated virus AAV, which comprises contacting the cells to be ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/864A61K47/46A61K45/00
CPCC12N15/86A61K47/46A61K45/00C12N2750/14143C12N2800/107
Inventor 陈邵宏郝丹丹史天永和赛超牛琳琳
Owner CHIGENOVO CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com